Acuta Capital Partners, LLC Portfolio Holdings

Acuta Capital Partners, LLC

  • $122 Million
  • Q1 2024

Acuta Capital Partners, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $122 Million distributed in 33 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $24M, Mersana Therapeutics, Inc. with a value of $9.7M, Taysha Gene Therapies, Inc. with a value of $9.57M, Rocket Pharmaceuticals, Inc. with a value of $8.8M, and Sarepta Therapeutics, Inc. with a value of $8.31M.

Examining the 13F form we can see an decrease of $5.99M in the current position value, from $128M to 122M.

Acuta Capital Partners, LLC is based out at Belmont, CA

Below you can find more details about Acuta Capital Partners, LLC portfolio as well as his latest detailed transactions.

Portfolio value $122 Million
Healthcare: $122 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$439M
$24 Million 19.61% of portfolio
2,635,287
Q1 2024 Added 101.17%
$226M
$9.7 Million 7.93% of portfolio
2,164,628
Q1 2024 Reduced 8.59%
$166M
$9.57 Million 7.82% of portfolio
3,333,333
Q1 2024 Reduced 7.13%
$1.61B
$8.8 Million 7.2% of portfolio
326,787
Q1 2024 Reduced 10.72%
$11.4B
$8.31 Million 6.79% of portfolio
64,162
Q1 2024 Reduced 9.12%
$4.17B
$7.16 Million 5.85% of portfolio
104,830
Q1 2024 Reduced 10.69%
$206M
$5.39 Million 4.4% of portfolio
792,000
Q1 2024 Added 50.83%
$1.65B
$5.24 Million 4.28% of portfolio
184,500
Q1 2024 Added 24.8%
$3.36B
$4.63 Million 3.79% of portfolio
143,777
Q1 2024 Reduced 10.14%
$1.56B
$4.57 Million 3.74% of portfolio
109,000
Q1 2024 Added 57.06%
$37.8M
$4.33 Million 3.54% of portfolio
1,849,402
Q3 2022 Added 20.92%
$406M
$4.17 Million 3.41% of portfolio
250,609
Q1 2024 Reduced 22.79%
$2.39B
$3.67 Million 3.0% of portfolio
78,403
Q1 2024 Reduced 10.4%
$477M
$3.49 Million 2.86% of portfolio
199,433
Q1 2024 Reduced 29.15%
$226M
$3.05 Million 2.49% of portfolio
465,079
Q1 2024 Reduced 16.24%
$3.28B
$2.98 Million 2.44% of portfolio
92,346
Q1 2024 Reduced 22.72%
$1.38B
$1.92 Million 1.57% of portfolio
90,000
Q1 2024 Reduced 87.17%
$7.46B
$1.67 Million 1.37% of portfolio
61,718
Q1 2024 Added 109.21%
$1.99B
$1.62 Million 1.32% of portfolio
55,262
Q1 2024 New
$356M
$1.43 Million 1.17% of portfolio
103,992
Q1 2024 New
$431M
$1.31 Million 1.07% of portfolio
397,884
Q1 2024 New
$10.5M
$1.08 Million 0.88% of portfolio
173,320
Q1 2024 New
$2.81B
$933,000 0.76% of portfolio
20,000
Q1 2024 New
$6.35B
$920,000 0.75% of portfolio
13,300
Q1 2024 New
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 45.83%
Verastem Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 10.83%
Leap Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 12.6%
-
$0 0.0% of portfolio
-
Q2 2022 New
Cellectar Biosciences Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 69.95%
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 33.51%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 219.75%

Summary

  • Portfolio
  • No. of Stocks 33
  • Current Value $122 Million
  • Prior Value $128 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 6 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email